Atrial fibrillation in pregnancy: a growing challenge

Area of Science:

• Cardiology
• Maternal-Fetal Medicine
• Pharmacology

Background:

• Atrial fibrillation (AF) is an infrequent but complex complication during pregnancy.
• Limited data exist on AF prevalence, prognosis, and management in pregnant individuals.
• While often benign, AF can cause severe hemodynamic issues in those with comorbidities.

Purpose of the Study:

• To review the challenges and current strategies for managing atrial fibrillation in pregnancy.
• To highlight the difficulties in therapeutic decision-making due to placental transfer of medications.
• To emphasize the need for further research into AF pathophysiology and treatment in this population.

Main Methods:

• Review of existing literature on atrial fibrillation in pregnancy.
• Analysis of treatment considerations, including pharmacologic and electrical cardioversion.
• Discussion of antithrombotic therapy selection and fetal implications.

Main Results:

• Hemodynamic instability necessitates prompt electrical cardioversion.
• Pharmacologic cardioversion with appropriate antithrombotics is an option for stable patients.
• Medication choice is complicated by potential fetal effects and placental transfer.

Conclusions:

• Maternal treatment is prioritized, but fetal well-being must be carefully considered.
• Novel oral anticoagulants present additional therapeutic challenges.
• Further clinical trials are essential to improve evidence-based management strategies for AF in pregnancy.